Hantavirus on the High Seas Part 2: What Changed, What Didn’t, and Why the Conversation Got So Messy

Summary

In Part 2 of Hantavirus on the High Seas, we revisit the evolving Andes virus outbreak linked to the MV Hondius cruise ship and ask a different set of questions than we did last week. What actually changed as new evidence came in? What did genomic sequencing reveal about likely transmission? And why did the public conversation around “airborne,” “close contact,” and public-health precautions become so chaotic so quickly?

This episode explores how scientific understanding shifts during an active outbreak investigation, why public-health responses often escalate before certainty exists, and what WHO’s newly released technical guidance reveals about how outbreak management actually operates behind the scenes. We also unpack the growing tension between scientific nuance, operational precaution, and post-COVID public interpretation as international authorities respond to a cluster that now spans multiple countries.

Listen here or scroll down to read the full episode.

Full Episode (annotated citations are at the end of the post after Heather's signature)

Last week, this story was mostly about uncertainty. A ship at sea, people getting sick in different countries, and one big question hanging over everything: is this virus actually spreading from person to person?

At the time, the honest answer was: we didn’t know yet.

And that uncertainty mattered because Andes virus occupies a strange place in infectious disease. Unlike most hantaviruses, it can spread between people under certain circumstances. But historically, those transmission chains have been limited, context-dependent, and difficult to generalize from.

So last week’s episode wasn’t really about whether this outbreak was “the next pandemic.” It was about how we think during uncertainty. About the difference between what we know, what we think, and what we worry about.

But since then, the situation evolved quickly. The ship docked. Passengers dispersed internationally. Additional cases were identified. Genomic sequences were released. Public health agencies escalated portions of the response. And online? The conversation got louder, sharper, and much messier.

This Hantavirus on the High Seas Part 2: What Changed, What Didn’t, and Why the Conversation Got So Messy

So this week, I want to revisit the questions from the first episode and ask: What did we actually learn? And honestly, I think this outbreak has become less a story about a single virus and more a story about what happens when scientific uncertainty collides with public memory after COVID.

What Changed This Week

Let’s start with the timeline.

The outbreak cluster linked to the MV Hondius continued to expand after passengers disembarked internationally in late April. Multiple countries became involved in testing, sequencing, contact tracing, and patient management.

By now, as of 12 May, WHO is reporting 11 cases linked to this event, including 3 deaths. Nine of those 11 are laboratory‑confirmed and two are classified as probable. And crucially, all of them are passengers or crew from this ship. In other words, we do not currently have confirmed cases in people who were never on board. So it’s a small but serious cluster scattered across several countries, not hundreds of cases.

The first known patient—let’s call him Case 1—developed symptoms on April 6, just a few days after the ship left its port in Tierra del Fuego. He had fever, headache, abdominal and gastrointestinal symptoms, then deteriorated quickly and died on April 11. He was never tested at the time, but based on what we now know, he’s treated as the earliest likely case in this cluster.

His spouse, Case 2, became ill later after disembarking at St. Helena and traveling on through South Africa. She died in Johannesburg, and testing after her death confirmed hantavirus infection. Her case became one of the first solid anchors for the investigation.

From there, we start to see a pattern: several additional passengers and crew developed severe illness over the following days and weeks. Some were evacuated to intensive care in South Africa. Others, including the ship’s doctor and one of the expedition guides, were transferred to the Netherlands. Another passenger tested positive after returning home to Switzerland. Together, these cases made it clear this was not a single tragic event, but a connected outbreak spanning multiple countries.

WHO has been very explicit that, given the virus’s long incubation period and the dynamics of spread on a ship, they expect more cases among this group in the coming weeks. But they’re also saying there is no sign right now that this is the beginning of a larger community outbreak. And that is supported by what we’re seeing.

At the same time, sequencing data started arriving from multiple international laboratories. And this is where the story shifted meaningfully. The viruses isolated from different patients were remarkably similar genetically. In fact, across most genome segments, the sequences were essentially identical. Investigators identified only two single-nucleotide differences — each in separate patients — and both were synonymous mutations, meaning they did not change the resulting viral protein.

In plain language:

The viruses look extremely closely related. And that matters because it supports the idea that these infections likely trace back to a single spillover event — or a very small number of closely related spillovers — rather than many unrelated exposures. In other words, these viruses look like cousins from the same family gathering, not strangers who just happen to share a last name.

Now, it’s important not to overstate this. The genomic data do not prove exactly how transmission occurred. The investigators themselves were careful about that. They explicitly noted that the data support a scenario involving an initial zoonotic introduction followed by human-to-human transmission, but they also emphasized that multiple people could still have been exposed to the same environmental source.

So compared to last week, some questions became clearer.

Others didn’t.

Revisiting the Questions From Last Week

All right. Let me come back to the three questions from last week and after updating answers for each, I’ll define what we now know, what I think based on the current evidence, and what still sits in the worry category.

Question 1: Could this be spreading person-to-person?

Compared to last week, the answer now is: yes, at least to some extent. We still don’t have the full transmission chain mapped out, and I expect more cases to be identified as we move through the incubation window. But the combination of clustering patterns, health‑care–associated illness, the timing of some later cases, and highly similar viral genomes are exactly what I meant last week when I described the kind of evidence that would move the needle for me. This is the needle moving based on evidence. This is science as a process: updating confidence as better evidence arrives.

Question 2: Could all cases have been infected before boarding?

Our first question mostly answers this one. The earliest cases still strongly support pre‑boarding infection, and we may never fully know whether those earliest infections came from one spillover event or several closely related exposures before boarding. But we know now there were human‑to‑human infections on the ship at the very least, and maybe beyond. Those data are still coming in, and the genomic report explicitly notes that environmental investigations—including rodent testing and exposure reconstruction—are still needed to fully resolve how many spillover events may have occurred.

Question 3: Does this mean we’re looking at a highly transmissible pandemic virus?

Still no. And this matters a lot, because people often hear “person‑to‑person transmission” and mentally translate it into “COVID‑level spread,” but those are not the same thing. There is still no evidence of sustained community transmission. No evidence of explosive spread dynamics. No evidence that this virus behaves remotely like measles, influenza, or SARS‑CoV‑2.

What we are seeing remains much more consistent with what has historically been observed with Andes virus: limited transmission under specific conditions. That’s not nothing. But it is a very different epidemiologic picture from a rapidly spreading respiratory pandemic virus.

And this is one place where public communication often collapses. People hear either:

“Nothing to worry about.”

or

“This is the next COVID.”

But many real outbreaks live in the middle space between those extremes. This is one of them.

And again, every current case so far was on the ship. We do not currently have confirmed cases in people who were never on board. If that changes, the most likely scenario would be a close contact with someone who was symptomatic. If we start seeing infections in people without that kind of link, that gives us more data—and whether that moves an event from outlier to “typical” depends on how often we see it.

So, where does that leave us on the Know / Think / Worry scale this week, compared to last?

We know: this cluster is linked to the ship; all current cases are passengers or crew; there has been some human‑to‑human transmission; and there is still no sign of sustained community spread.

I think: the most likely picture is a pre‑boarding spillover with limited person‑to‑person transmission in close‑contact settings, consistent with what we’ve seen from Andes virus before.

And what I still worry about: Without evidence that it’s happening yet, I’m watching for the possibility of broader transmission chains showing up in people without clear close‑contact links. That’s what everyone is watching for.

OK, so that’s where we are on those questions. But alongside the science, something else started happening this week: the communication itself became part of the story.

Scientists vs Public Health

One thing that became very obvious this week is that public health and science are not operating under identical rules.

Scientists ask: “What does the evidence currently support?”

Public health asks: “What actions reduce harm while evidence is incomplete?”

Those are related questions. But they are not the same question. And that difference explains a lot of the tension people noticed online including:

• Why some scientists sounded cautious.

• Why some agencies escalated recommendations more quickly.

• Why different countries implemented slightly different approaches.

• And why messaging sometimes sounded inconsistent even when everyone involved was acting reasonably.

Precautionary public-health measures are not proof the science is settled. They are responses to uncertainty combined with consequences. If the cost of underestimating a risk is high enough, public health often acts before absolute certainty exists. That’s not deception. That’s outbreak management.

The Language Problem

A huge amount of public disagreement right now isn’t actually about evidence. It’s about language. People are often using the same words while meaning completely different things.

For example: “Airborne”

This word became a flashpoint almost immediately. Technically, hantaviruses absolutely can be transmitted through the air from aerosolized rodent excreta. That has always been true and acknowledged, and does not, by itself, mean efficient human‑to‑human spread.

But after COVID, many people now hear “airborne” and interpret it as: “Spreads easily from person-to-person through shared indoor air like measles or SARS-CoV-2.”

And there’s a third category: spread through aerosols primarily at close range, without the kind of explosive long-distance transmission dynamics we associate with viruses like measles.

That is a completely different implication. So you ended up with people arguing past each other. One side saying: “It’s airborne.” The other responding: “No it isn’t.” When they were often talking about different concepts entirely.

And just to underline how messy this is: even the people who do this full‑time don’t all mean the same thing when they say “airborne.” WHO actually convened a big technical consultation on this in 2024, with experts from multiple CDCs and aerosol scientists, because COVID made clear that different disciplines were using the word in conflicting ways.

Their compromise was to zoom out and talk about “transmission through the air” as the umbrella, and then split that into two more specific ideas: airborne transmission or inhalation—particles you breathe in, at short or long range—and direct deposition—heavier particles that arc out over a short distance and land directly on your eyes, nose, or mouth.

Crucially, they say infectious particles come in a whole range of sizes and there is no magic cutoff between “droplets” and “aerosols.” That’s progress. But even in that report, there were still areas where the experts couldn’t reach full consensus, and they’re very up front that this is a starting point, not a perfect final definition. That report is available in the blog post for this episode or on WHO’s website.

So in this episode, when I talk about how Andes virus spreads between people on this ship, I’m going to be specific about patterns—limited transmission in close, prolonged contact—rather than trying to win the internet fight over whether that does or doesn’t “count” as airborne. Because at this point, even the official terminology is still catching up.

And there’s the phrase “Prolonged Close Contact”

This one may have been even more confusing. You might have seen a post I made about this, because it seems like people hear ‘prolonged close contact’ and picture something much narrower than what public health actually means by it…usually some kind of intimate physical proximity. During COVID, public-health agencies operationally defined prolonged close contact as: within six feet for a cumulative fifteen minutes over twenty-four hours. And for “Prolonged direct close contact” it’s: within 6 ft for 15 consecutive minutes or longer.

But take a breath before you yell at me: there is nothing biologically magical about fifteen minutes. That number was never meant to imply transmission is impossible at fourteen minutes and suddenly dangerous at sixteen. It’s an operational threshold used to identify interactions more likely to involve meaningful exposure.

In reality, infectious exposure behaves more like a dose-response relationship: the more virus you encounter—and the longer or more times you encounter it—the greater the probability of infection becomes.

So when public-health officials describe Andes virus transmission as requiring ‘prolonged close contact,’ they are usually communicating something qualitative, not invoking a precise biological cutoff. They mean this does not appear to spread efficiently through casual passing encounters. That is very different from saying transmission requires extraordinary intimacy or hours of exposure.

And honestly, this is one place where public-health language often collides badly with how the rest of us interpret words emotionally. Because listeners hear:“close contact”

and mentally translate it into:“only family members hugging each other for hours.”

While public-health investigators may simply mean: repeated indoor interactions, shared cabins, caregiving exposure, extended conversations, or cumulative time spent near an infectious person.

And of course, me clarifying this is not intended to make people panic. It’s to clarify. It in no way is panic-inducing. But it does help us understand what we’re seeing in the public health response.

And after COVID, many people became hyperaware of these definitions — sometimes in ways that are useful, and sometimes in ways that make outbreak communication feel strangely technical and mistrustful at the same time.

One example that keeps getting discussed online comes from the large 2018 Andes virus outbreak in Epuyén, Argentina. In that outbreak reconstruction, there was a case where investigators were reportedly unable to identify any clear exposure other than a very brief encounter at a social gathering—basically passing near an infectious person while walking to a bathroom. People understandably latch onto that story because it feels dramatic. It sounds like proof that the virus must spread easily through the air in the same way as something like measles or COVID. But that’s not actually what investigators concluded. What they concluded was that they were unable to identify another clear exposure.

Outbreak reconstruction is imperfect. Exposure histories are incomplete. People forget interactions. Environmental exposures can go unnoticed. Brief encounters are hard to characterize after the fact. And sometimes transmission events genuinely are unusual outliers. So that case is important because it suggests that under at least some circumstances, relatively brief exposure may be sufficient for transmission. But one unusual event does not automatically tell us how transmission behaves most of the time. In other words, A single unusual transmission event does not automatically redefine the overall transmission behavior of a virus.

So when you hear “prolonged close contact” in the context of this cruise, think shared cabins, shared tables, medical care, and repeated time in the same indoor spaces—not just brushing past someone once in a hallway.

And just to be clear: that bathroom story comes from later reporting on the outbreak reconstruction, not from a single line in the NEJM paper itself. The paper shows that social‑event exposures and close contact can be enough for transmission, but it doesn’t narrate that specific moment in that kind of detail. The way it’s being cited online often overshoots what the actual data can support.

Humans are naturally drawn to extreme examples. We remember the extraordinary case much more vividly than the hundreds of ordinary non-transmission events surrounding it. Right? Measles looks different epidemiologically because we repeatedly see explosive spread across casual contact networks. The pattern itself becomes unmistakable. With Andes virus, even in outbreaks where person-to-person transmission occurs, what we generally see are smaller, more limited chains associated with close-contact settings.

So when scientists say transmission appears limited or context-dependent, they are not claiming brief transmission is impossible. They are describing the overall pattern observed across outbreaks. So one unusual transmission event can expand what we think is possible. But if that unusual event starts happening regularly, that’s when it stops being an outlier and starts redefining the pattern itself.

This outbreak really exposed that tension between scientists and public‑health officials. Scientists are trying to characterize reality accurately. Public health is trying to reduce harm under uncertainty. Sometimes those goals align neatly; sometimes they pull the messaging in different directions. And after COVID, a lot of people now hear that tension as dishonesty rather than as a normal, if messy, process.

I think that’s part of why this outbreak became psychologically loud relative to the number of cases involved.

And while we’re talking about how these definitions get used, I want to add one more piece that I think is really important.

You may have seen people online saying that Andes virus is known to spread “48 hours before symptoms start and 48 hours after they begin,” quoting what was said in an interview, by the author of the NEJM superspreading paper from the 2018–2019 Argentina outbreak. That NEJM paper is absolutely the key reference for that outbreak. But the paper itself does not actually demonstrate fully presymptomatic person‑to‑person transmission.

I emailed the corresponding author of that study, Gustavo Palacios, and asked him directly about this, and he confirmed that interpretation. So, first of all, thank you to Dr. Palacios for taking the time to respond so thoroughly to my question in the midst of this outbreak and I look forward to having a longer conversation when things settle down.

OK, so he said that what their analysis could reconstruct, was transmission very early in illness: in their data, 17 of 33 secondary cases had exposure when the transmitting patient had been symptomatic for about one day, and 19 of 33 within one to three days. For the rest, the timing just couldn’t be nailed down. They also found that higher viral load was associated with transmission—so people were more likely to infect others when their viremia was high.

In other words, the evidence in that paper supports early symptomatic or prodromal transmission—often around the first recognized day of illness—rather than clear, proven spread from people who felt completely well.

So where does that “48 hours before to 48 hours after” window come from? According to Dr. Palacios, that was a precautionary contact‑tracing window used by Argentine public‑health authorities. It was designed as a safety margin: if viral load is already high at or very close to the first symptoms, then it is probably rising in the hours before those symptoms are clearly recognized. And of course, the very first prodromal symptoms are often nonspecific—people can miss or downplay them.

The key point is that this window is a public‑health tool, not a claim that the NEJM study proved fully asymptomatic transmission. It’s a good example of the pattern we keep seeing: scientific evidence showing “early symptomatic transmission associated with high viral load,” and then a broader, precautionary time window used operationally to make sure contact tracing doesn’t miss anyone.

That distinction really matters, because when those operational windows get repeated without context, they can easily turn into “this virus definitely spreads widely before symptoms,” which is a much stronger—and in this case, not yet supported—claim. And once you see that pattern, you start spotting it everywhere in this outbreak.

And behind all the sequencing charts, technical guidance documents, and online arguments were real people sitting in cabins thousands of miles from home waiting to find out whether they were infected with a virus known for severe respiratory failure.

And nowhere is this more evident than in the next story that I think really captures the strange intersection of uncertainty, logistics, and outbreak response we’ve been talking about. One of the later suspected cases linked to the cruise outbreak ended up on Tristan da Cunha — the most remote inhabited British territory in the world. It sits deep in the South Atlantic, has no airport, and is normally accessible only by boat.

And because oxygen supplies on the island were reportedly becoming critically low, the British military launched what was honestly a pretty extraordinary operation to get medical support there in time.

An RAF A400M flew thousands of kilometers across the South Atlantic, refueled midair, and a specialist Army team — including military clinicians — parachuted onto the island with oxygen supplies and medical equipment.

And when you hear a story like that, it’s easy for the imagination to immediately jump toward: “This must mean authorities think this virus is spreading uncontrollably.”

But that’s not actually what this operation tells us.

What it tells us is that hantavirus can cause severe respiratory disease, that Tristan da Cunha is extraordinarily isolated, and that public-health and government systems often respond aggressively when uncertainty, remoteness, and high clinical stakes overlap.

In other words: the scale of a response does not necessarily say anything about transmission. Sometimes it speaks to the scale of the consequences if systems fail in a difficult environment.

What WHO’s technical guidance reveals

While everyone’s arguing publicly—about “airborne,” about “close contact,” about whether WHO was minimizing or fearmongering—WHO released something today that’s much less dramatic and much more revealing: a technical note for how to actually disembark passengers and crew from this ship and manage them afterward.

This document isn’t written for headlines. It’s written for port health authorities, national public‑health teams, and people who actually have to move human bodies through space: ship captains, ambulance crews, screening teams in the port, and public‑health staff in the countries where passengers are going to land. And when you read it next to the public messaging, you can really see the tension I’ve been talking about—between operational precautions and public‑facing certainty.

On the public side, WHO and national authorities keep emphasizing that the risk to the general public remains low. They describe measures as precautionary. They talk about uncertainty and say clearly that investigations are ongoing and recommendations may change as new data come in. That’s the part most people hear.

But operationally, this document is taking the possibility of human‑to‑human transmission very seriously. It recommends that suspected cases be evacuated in ambulances by teams wearing full personal protective equipment: respirators like N95s or FFP2s, eye protection, gowns, and gloves. It tells responders to treat PPE as infectious waste, to isolate symptomatic people in dedicated areas with their own bathrooms, and to keep health‑care workers in respirators and eye protection during transfer and care.

For disembarkation, it goes even further. It recommends that passengers and crew come off the ship one by one, in a staggered process, all wearing well‑fitted respirators—again, N95 or FFP2—until they’ve been screened. Screening areas are supposed to be preferably outdoors or in well‑ventilated indoor spaces, with distancing, one‑way flow, and separate facilities for staff. Windows on transport coaches should be kept open for ventilation. Staff in the screening area are told to wear masks and have ready access to hand‑hygiene stations.

And it doesn’t stop when people leave the port. For asymptomatic passengers, the guidance lays out 42 days of follow‑up after disembarkation—the full upper end of the incubation window. During that time, they’re advised to avoid contact with others, stay in designated facilities or home quarantine depending on the country, and even avoid returning to work if they’re health‑care workers. All travel, national and international, is discouraged for that entire 42‑day period.

Inside the home, they suggest that contacts sleep in separate rooms if possible, limit social interactions, wear respirators like N95 or FFP2 when they can’t avoid contact, keep distance, and maintain strict hand hygiene. They even note that routine testing of asymptomatic contacts isn’t required for public‑health purposes but can be considered for research—to understand viral shedding and transmission dynamics over time. That’s a clear signal that they are actively interested in the possibility of asymptomatic or presymptomatic shedding, even while saying the evidence there is still limited.

So you end up with this striking picture: in public messaging, the language is “risk is low,” “precautionary measures,” “we’re still learning.” In the operational guidance, you see respirators, staggered one‑by‑one disembarkation, outdoor or highly ventilated screening, 42‑day monitoring, discouraged travel, and advice to limit even household contact.

Those two things are not actually contradictory. They’re answering different questions.

The scientific question is: what does the evidence currently support about transmission and risk? That’s where you hear phrases like “limited person‑to‑person transmission under specific circumstances” and “no evidence of sustained community spread.”

The public‑health operations question is: given what we don’t know yet, and the stakes if we don’t have the whole story, what is the safest way to handle these specific people right now? That’s what this technical note is doing. It assumes a worst‑reasonable case while the science catches up, and then builds systems—ventilation, PPE, quarantine, travel restrictions—to reduce the chance that a bad scenario unfolds. Precautionary respirator use does not by itself resolve the exact relative contribution of droplets, aerosols, or other transmission routes.

This is why you can see N95s and 42‑day monitoring in the operational plan at the same time that WHO is telling the general public not to panic. The aggressive precautions do not mean “we secretly know this behaves like measles or like COVID.” They mean: this is a severe disease, with international dispersal, incomplete exposure histories, and a long incubation period, and the cost of under‑reacting for this small group of people is high.

One of the quiet lessons here is that technical guidance often tells you more about institutional risk assessment than press conferences do. Not because authorities are hiding the truth, but because these two products have different jobs. Public messaging tries to prevent panic, maintain trust, and give people clear, simple actions. Technical notes like this one try to prevent further spread under uncertainty—even if that means using measures that would sound alarming if you dropped them straight into a headline.

And that’s why this document is so fascinating to me. It gives us something the public rarely gets to see directly: what outbreak management actually looks like when authorities are trying to reduce risk before the science is fully resolved. It’s the operational side of the same uncertainty story we’ve been talking about all along.

Those procedures aren’t just theoretical. They were used to get people off the ship in Tenerife and then to their respective countries, where national authorities are now following WHO’s recommendation for a 42‑day home or facility quarantine and daily monitoring. And Tuesday morning the ship left Tenerife with a skeleton crew and medical team, headed to the Netherlands.

And of course, once these plans hit real life—photos from buses, interviews from the dock—people start hunting for moments where it looks like WHO or national authorities aren’t living up to their own guidance. Sometimes that’s a real problem; sometimes it’s a snapshot with no context. My goal here is not to referee every viral image, but to show you what the actual technical plan looked like and why it can coexist with “risk to the general public is low.

There’s one more development this week that I think is worth mentioning, because it shows the same pattern from yet another angle—this time inside the virology community itself.

The International Hantavirus Society, together with dozens of hantavirus researchers, released a statement on Andes virus and what we now know about its transmission. If you’ve followed this field for a while, you know that for years people talked about Andes person‑to‑person spread with a lot of caution and caveats—not because there was no evidence, but because the epidemiology is messy, outbreaks are rare, and shared environmental exposure is hard to fully rule out.

What’s striking in this new statement is how clearly the language has shifted. The authors write that human‑to‑human transmission of Andes virus “should no longer be regarded as merely hypothetical or unproven.” That’s a field saying out loud, in public: the weight of evidence has passed a threshold. This isn’t just a handful of curious case reports anymore.

Just as important is what they don’t say. They are not claiming Andes behaves like measles or like COVID. The statement emphasizes that transmission is typically associated with close or prolonged contact, that efficient community spread has not been observed, and that outbreaks so far have shown context‑specific, limited chains rather than runaway epidemics. The nuance didn’t disappear. The consensus just became more explicit.

To me, this is a really clean example of what scientific consensus actually looks like in motion. Science isn’t just “one day there was no fact, the next day there was.” It’s an ongoing process of calibrating confidence, refining language, and deciding when the evidence has become strong enough that the way we talk about something should change.

And from the outside, watching that process unfold can feel confusing. The language changes. The confidence shifts. Different experts emphasize different parts of the same data. But that doesn’t necessarily mean the science is broken. Sometimes it means you’re seeing consensus form in real time—on top of the same messy, partial evidence that everyone is trying to make sense of together.

What We Still Do Not Know

Even with the new evidence, major uncertainties remain which is normal for an outbreak investigation one week in. So, here’s what’s still unknown:

• We still do not know the exact transmission chains.

• We do not fully know the relative role of environmental exposure versus secondary transmission.

• We still do not know whether any asymptomatic or presymptomatic transmission occurred.

• We don’t know the final case count as additional cases could still emerge during the remaining incubation window.

And importantly, investigators themselves continue to emphasize that the genomic analysis represents the current assessment and may evolve as additional samples and epidemiologic data become available.

Closing

One thing this outbreak revealed very clearly is how difficult it is for people to sit inside uncertainty without immediately filling it with certainty. It’s human nature. We want answers early. We want stable narratives. We want language that feels emotionally definitive.

But outbreaks rarely cooperate. Especially at the beginning. And it’s worth remembering: uncertainty is not incompetence. Updating is not contradiction. Precaution is not proof. And communication still struggles when science, public health, media incentives, and public fear collide.

On Twitter, Dr. Krutika Kuppalli, summed this up in a way that’s been echoing in my head. She said that with this outbreak, “we are watching modern outbreak response collide with modern information chaos in real time. The virus is spreading far slower than the information about it. And that may be one of the defining public health challenges of our era.”

And that’s exactly why it matters to practice living in that uncomfortable middle space: noticing the difference between what we know, what we think, and what we’re still trying to rule out, even when the information is moving faster than the data.

It might be helpful to let evidence sharpen the picture a little before we emotionally lock the story into place. Because real outbreak investigations don’t unfold in clean straight lines. They unfold through partial information, revised interpretations, and gradual increases in confidence.

That’s not science failing. That’s science functioning in real time. And right now, this story is still unfolding. The picture is sharper than it was last week. But we are still watching it come into focus.

---

If anything in this episode raised questions for you, I’d love to hear them—please reach out.

And if you haven’t already, you can sign up for my free newsletter, Field Notes. That’s where I take one thread from the episode and follow it somewhere else entirely, share a little behind‑the‑scenes process, and keep a running log of outbreak updates. You can subscribe at infectiousddose.com, where you’ll also find the Field Notes archive, plus companion posts for every episode—transcripts, show notes, and full citations.

For a comprehensive episode on American hantaviruses with a focus on Sin nombre, see No Name, No Mercy: The Hantavirus That Killed Betsy Arakawa.

Thanks for being here. We'll be back to scheduled programming next week with a look at how Spring can make us miss infections. No really, we will. Maybe. Until then, stay healthy, stay informed, and spread knowledge not diseases.

Annotated Citations

Palacios, G. May 2026. Preliminary analysis of Orthohantavirus andesense virus sequences from a cruise-ship related cluster. https://virological.org/t/preliminary-analysis-of-orthohantavirus-andesense-virus-sequences-from-a-cruise-ship-related-cluster-may-2026/1029

→→ Early international genomic analysis of Andes virus cases linked to the MV Hondius outbreak. The report found extremely limited viral diversity across sequenced samples, supporting a scenario involving a single—or very limited number of—zoonotic spillover event(s) followed by likely human-to-human transmission during the outbreak. Also important for its careful framing of uncertainty: investigators explicitly note that the genomic data alone cannot fully exclude shared environmental exposure as an alternative explanation for some infections.

WHO. 2024. Global technical consultation report on proposed terminology for pathogens that transmit through the air.

https://www.who.int/publications/m/item/global-technical-consultation-report-on-proposed-terminology-for-pathogens-that-transmit-through-the-air

→→ WHO technical consultation report developed to clarify terminology surrounding airborne, aerosol, droplet, and inhalation transmission after years of confusion and inconsistency during the COVID-19 pandemic. Particularly valuable for explaining how experts distinguish between different modes of transmission through the air and why public-health communication around terms like “airborne” often becomes contentious or misunderstood. Useful background for discussions of Andes virus transmission language, especially the difference between aerosol transmission, close-range inhalation exposure, and highly efficient long-range airborne spread.

Martínez, VP, et al. 2020. "Super-Spreaders” and Person-to-Person Transmission of Andes Virus in Argentina. N Engl J Med. https://www.nejm.org/doi/full/10.1056/NEJMoa2009040

→→ G. Palacios corresponding author. Landmark reconstruction of the 2018–2019 Andes virus outbreak in Epuyén, Argentina, which provided some of the strongest epidemiologic evidence for person-to-person transmission of Andes virus. Using contact tracing, symptom timelines, and viral sequencing, the study identified multiple transmission chains and superspreading dynamics associated with close-contact social settings. Particularly valuable for demonstrating that Andes virus transmission can occur early in illness and for shaping current thinking around close-contact transmission patterns, while also illustrating the challenges of reconstructing precise exposure events during outbreak investigations.

Toledo, J. et al. 2022. Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiab461

→→This systematic review evaluates the evidence supporting person-to-person transmission of hantaviruses, with a particular focus on Andes virus outbreaks in South America. The authors review epidemiologic investigations, transmission chains, and virologic data from published studies and conclude that human-to-human transmission appears possible and is most strongly associated with Andes virus in settings involving close, prolonged contact. The review also notes that many investigations cannot fully exclude shared environmental exposure, an important limitation when interpreting suspected transmission events during outbreak investigations.

Ruscetti A, et al. 2022. Healthcare personnel early return-to-work program after higher-risk SARS-CoV-2 exposure: A learning health system quality improvement project

American Journal of Infection Control.

→→ Healthcare-system quality improvement study examining return-to-work protocols for healthcare personnel after higher-risk SARS-CoV-2 exposure. Particularly useful in this episode not for its COVID findings themselves, but because it explicitly references operational public-health definitions of “prolonged close contact” and “prolonged direct close contact,” illustrating how these terms are often used as practical exposure-management thresholds rather than precise biological cutoffs. Helpful background for understanding why public-health language around “close contact” can sound emotionally misleading or overly categorical when interpreted outside its operational context.

UK Ministry of Defence. May 10, 2026. Press release on the Tristan da Cunha parachute medical mission. https://www.gov.uk/government/news/military-conducts-daring-parachute-drop-to-deliver-critical-medical-support-to-tristan-da-cunha

→→ UK government press release describing the emergency military-medical response to a suspected hantavirus case on Tristan da Cunha during the 2026 MV Hondius outbreak. Particularly valuable for illustrating the operational realities of outbreak response in remote settings: military clinicians and paratroopers were deployed by RAF aircraft to Britain’s most isolated overseas territory after local oxygen supplies became critically low. Useful for understanding how severity of disease, geographic isolation, and uncertainty can drive highly visible precautionary responses even when overall public risk remains low.

WHO. May 12, 2026. Update on #hantavirus https://x.com/WHO/status/2054207705452020119?s=20

→→ This WHO post provides an update between DON reports. It indicates as of May 12, "a total of 11 cases, including 3 deaths, have been reported. Nine of the 11 cases are confirmed, and the other 2 are probable. All are among passengers or crew on the ship."

WHO. May 8, 2026. Hantavirus cluster linked to cruise ship travel, Multi-country. Disease Outbreak News. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599

→→This WHO Disease Outbreak News report summarizes the currently known epidemiologic details of the hantavirus cluster associated with international cruise ship travel, including confirmed and suspected cases, timelines of illness onset, and ongoing public health investigations. It serves as the primary source for the current outbreak timeline and illustrates the challenges of communicating evolving scientific information in real time.

WHO. May 5, 2026. Hantavirus cluster linked to cruise ship travel, Multi-country. Disease Outbreak News. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599

→→This WHO Disease Outbreak News report summarizes the currently known epidemiologic details of the hantavirus cluster associated with international cruise ship travel, including confirmed and suspected cases, timelines of illness onset, and ongoing public health investigations. It serves as the primary source for the current outbreak timeline and illustrates the challenges of communicating evolving scientific information in real time.

WHO. May 12, 2026. Technical note for the disembarkation and onward management of passengers and crew in the context of an Andes virus-associated cluster MV Hondius cruise ship https://www.who.int/publications/m/item/who-technical-note-for-the-disembarkation-and-onward-management-of-passengers-and-crew-in-the-context-of-an-andes-virus-associated-cluster-mv-hondius-cruise-ship

→→ WHO operational guidance document outlining procedures for disembarkation, quarantine, screening, transport, and follow-up of passengers and crew associated with the MV Hondius Andes virus outbreak. Particularly valuable for understanding how public-health systems operationalize precautionary outbreak management under scientific uncertainty, including recommendations for respirators, ventilation, staggered disembarkation, 42-day monitoring, and international coordination measures while transmission dynamics remain under investigation.

Maes, P and Tischler, N. May 12, 2026. International Hantavirus Society statement on the current Andes virus outbreak investigation (Version 4).

https://zenodo.org/records/20134326

→→ Consensus statement from the International Hantavirus Society and dozens of hantavirus researchers, clinicians, and virologists addressing the 2026 MV Hondius outbreak and the broader evidence for Andes virus person-to-person transmission. Particularly important for its explicit statement that human-to-human transmission of Andes virus “should no longer be regarded as merely hypothetical or unproven,” while also emphasizing that current evidence does not support efficient community spread or pandemic-like transmission dynamics. Useful as a snapshot of how scientific consensus and public-health framing around Andes virus transmission appear to be evolving in real time.